Transforming Lyme disease diagnosis through AI-powered testing

Holly Ahern, microbiologist and Chief Scientific Officer, shares how ACES Diagnostics is revolutionizing Lyme disease diagnosis with a machine learning–driven immunoassay that delivers over 95% accuracy in early-stage detection. Designed for clinical labs and rapid turnaround, the test overcomes limitations of traditional serology and empowers providers to treat Lyme disease before it progresses to chronic illness. With broad accessibility and insurance compatibility, this innovation could reshape how tick-borne diseases are diagnosed and managed.